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Objective. The aim of this study was to find a proper experimental design and to evaluate n-butyl-2-cyanoacrylate (Histoacryl) as
a fixation method for a light-weight and large pore PP mesh (Synthetic PP Mesh-1) using the sheep as an animal model. Methods.
Posterior vaginal implantation by means of episiotomy was used to implant 8 ewes which were evaluated macroscopically and
histologically at 3 months (𝑛 = 4) and 6 months (𝑛 = 4) post-surgery. In previous pilot studies anterior vaginal implantation was
evaluated, as well as different synthetic mesh materials, sizes and fixation methods (𝑛 = 1 to 3) during three weeks. In all cases a
clinical evaluation of the animal was performed. Results. A reduction in the mesh size (Synthetic PP Mesh-1) together with precise
application of the surgical glueHistoacryl to fix themesh yielded significantly better histocompatibility results (𝑃 < 0.01) compared
to larger size or other fixation methods. Conclusion. The combination of Synthetic PP Mesh-1 with Histoacryl offered a high degree
of graft integration without vaginal ulceration and a minimal foreign body reaction, being the sheep a proper animal model to test
these types of medical devices.
1. Introduction
Pelvic organ prolapse (POP) is a common occurrence that has
become more prevalent in view of the aging population. It is
not a life threating condition and death rate is almost nonex-
istent but it substantially affects the quality of life.The normal
occurrence of pelvic organ support defects in women has
still not been properly investigated. However, recent studies
have described a POP prevalence of 30–50% diagnosticated
by gynecologic examination in women between 45 and 85
years of age, with prevalence of symptomatology reported by
the patient ranging from 4 to 12% [1, 2].
Vaginal syntheticmeshes help reinforce pelvic floor tissue
and were proposed for use in reconstructive pelvic surgery
mainly to reduce the high rate of recurrences of patients oper-
ated with native-tissue methods [3–5]. Furthermore, the use
of prostheses allows for greater procedure standardization,
shorter surgery duration, and faster postoperative recovery.
However, transvaginal mesh surgery has been associated
with specific complications related to mesh quality, surgical
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Table 1: Summary of the different experimental groups showing mesh material and anchorage characteristics.
Experiment Experimentalgroup (𝑛) Surgical approach Type of mesh Anchorage used
Mesh size
(width-
length)
Follow-up
period
1 PP-1-Hist 3 anterior Synthetic PP Mesh-1 Histoacryl 0.4–0.8mL 5 × 5 cm 3 weeks
3 posterior
2 PP-1-PP 1 anterior Synthetic PP Mesh-1 PP 2/0 Premilene 3 × 4 cm 3 weeks
1 posterior 4 × 4 cm
3
Omy-TF-PP 2 posterior cPTFE Omyra Mesh PP 2/0 Premilene 2 × 2 cm 3 weeks
3 × 3 cm
PP-2-PP 1 anterior Synthetic PP Mesh 2 PP 2/0 Premilene 2 × 2 cm 3 weeks
1 posterior 3 × 3 cm
4
PP-1-Hist-3m 4 posterior Synthetic PP Mesh-1 Histoacryl 0.15–0.25mL 3 × 3.2 to 3.5
× 3.5 cm 3 months
PP-1-Hist-6m 4 posterior Synthetic PP Mesh-1 Histoacryl 0.15–0.25mL 3 × 3.2 to 3.5
× 3.5 cm 6 months
PP: Polypropylene; cPTFE: condensed polytetrafluoroethylene.
technique, and surgeon’s experience with the occurrence of
mesh exposure, in combination with dyspareunia, being the
most frequent complication [6, 7]. For this reason, the US
Food andDrugAdministration (FDA) has already issued two
Public Health Notifications (2008 and 2011) regarding the
potential for serious complications associated with transvagi-
nal placement of surgical mesh in repair of POP [8]. In
Europe, the Scientific Committee on Emerging and Newly
Identified Health Risks (SCENIHR) has also promoted a
request for a scientific opinion on the safety of surgical meshes
used in urogynecological surgery.
In consequence, the FDA is considering the approval
of a new rule for the Requirement for Premarket Approval
for Surgical Mesh for Transvaginal Pelvic Organ Prolapse
Repair, in which the manufacturers should conduct animal
studies to evaluate the in vivo performance of the meshes
in an appropriate animal model. Undoubtedly, in situations
in which transvaginal mesh is required, scientific preclinical
data should support the specific medical devices. Hence, the
present study using sheep as a preclinical animal model was
performed to assess the outcome of n-butyl-2-cyanoacrylate
(Histoacryl) as a fixation method for a light-weight and large
pore size PP mesh (synthetic PP Mesh-1). At the same time,
othermeshmaterials and fixationmethodswere used to com-
pare the different outcomes and try to discern which factors
were most directly related to a better host histocompatibility
and lower incidence of graft related complications.
2. Materials and Methods
2.1. Animals. A total of six adult Lacaune (60–80 kg body
weight) and 14 Ripollesa (35–70 kg body weight) ewes were
used in this study. All animals were, unless stated, multi-
parous (2–5 pregnancies). Sheep were housed at Servei de
Granges i Camps Experimentals, Universitat Auto`noma de
Barcelona. All sheep were kept at our facility for at least one
week before surgery and were incorporated into the study
after a physical examination as well as a hematological and
biochemical blood test to detect any subclinical condition
that could interfere in the experiment.
The animals were housed in individual boxes during a
week after surgery and thereafter in groups.Thediet consisted
of pelleted diet and ad libitum hay. Tap water was supplied ad
libitum.This study was conducted under protocols approved
by the Ethical Committee of the UAB (1600) and Generalitat
de Catalunya (6719).
2.2. Study Design. Three exploratory experiments were per-
formed previously to the main experiment to compare the
combination of PPmesh andHistoacryl with othermaterials,
mesh sizes, and fixation methods. In all the pilot studies the
follow-up time was three weeks, including a clinical monitor-
ing andmacroscopic and histologic score of the implantation
sites after euthanasia. All studies andmeshmaterials assessed
are summarized in Table 1.
A first pilot study was performedwith the 6 Lacaune ewes
to assess the clinical performance and histocompatibility of
the Synthetic PP Mesh-1 and Histoacryl as fixation method
manually delivered through a 1mL syringe (PP-1-Hist group).
All other studies were performed with Ripollesa ewes. The
rest of pilot studies served to define the experimental
approach: mesh size and material, suture versus Histoacryl
either manually or delivered by means of a specific device.
Once the results of the three pilot studies were analyzed, it
was decided to perform the main study, which was a long-
term study with 8 ewes assessing Synthetic PPMesh-1 in com-
bination with Histoacryl using the reduced mesh size and a
lower amount of Histoacryl. All ewes were implanted by
posterior approach and distributed in two different follow-up
periods (Table 1).
2.3. Implants and Fixation Methods. Synthetic PP Mesh-1 and
Synthetic PP Mesh-2 (B. Braun Surgical, S.A) have a pore size
between 2 and 2.5mm type Imesh [9], a weight of 40±5 g/m2
and a diameter thread of 0.125 ± 0.015mm. Teflon mesh,
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(a) (b)
Figure 1: Photographs showing episiotomy procedure and posterior site mesh insertion (synthetic PP Mesh-1). (a) Dashed line shows the
site where episiotomy with electric scalpel is performed. Arrows show the vaginal entrance and the anus. (b) Mesh placement on posterior
site between the rectum and the dorsal vaginal wall.
Omyra mesh (CEmarked by ProxyBiomedical), already used
in clinical practice, consists of a micromachined cPTFE
monolayer mesh with a density of 0.9 g/cm2 and a pore size
of 2.4mm. All meshes were sterilized with ethylene oxide and
cut into patches of the required size for each study.
Monomeric n-butyl-2-cyanoacrylate surgical glue His-
toacryl (B. Braun Surgical, S.A) already marketed for clinical
practice was used bymeans of 1mL syringe orHistoacryl Pro-
Set OFX applicator.
The nonabsorbable monofilament polypropylene suture
Premilene 2/0was used as the anchoring system in the second
and third pilot studies.
2.4. Surgery and Tissue Collection. Animals were premed-
icated with an intramuscular injection containing midazo-
lam (Hospira Inc.) (0.2mg/kg) and buprenorphine (Buprex
Schering-Plough, S.A) (0.01mg/kg). Anesthesia was induced
with Propofol (B. Braun) (4mg/kg) and the animals were
intubated andmaintained at a proper surgical anesthetic level
through inhaled oxygenated Isoflurane (Isovet, B. Braun)
(1.5–2.5%). A gastric catheter was placed into the stomach to
avoid possible ruminal reflux during anesthesia.
For both approaches, anterior and posterior, an epi-
siotomy was carried out (Figure 1). For the ewes implanted
by an anterior approach, the urethra was catheterized with a
Foley catheter and the vulva was incised in its ventral part,
dissecting all the tissue between the urethra and the vaginal
epithelium. The mesh was placed between the urine bladder
and the vagina, attached to the ventral part of the vagina. For
the ewes implanted in the posterior site, the vulva was incised
in its dorsal part, dissecting the tissue to allow the fitting
of the mesh between the vagina and the rectum (Figure 1).
Then the mesh was fixed in the dorsal vaginal wall. The
anterior implantation approach was surgically more difficult
compared with the posterior approach. The proximity of
the urethra to the implantation site and the narrow access led
to a very high risk of urethral injury.
When the mesh was anchored with 2/0 polypropylene
suture, a total of four stitches were made to secure it, one
in each corner. When Histoacryl was used, the surgical
glue was applied in each corner, with inner corners being
the first to be anchored. In all cases, special care was
taken to prevent the formation of folds in the mesh during
implantation. After mesh placement, the vaginal wall was
closed with a 2/0 synthetic short-term absorbable suture
(Safil Quick).
All animals received an intravenous antibiotic dose
of cefazoline (Kurgan, Normon S.A) just before starting
the surgical procedure. Once the surgery was finished, an
intramuscular dose of a long-acting antibiotic, ceftiofur
5mg/kg (Naxcel, Pfizer, S.A), was administered. Analgesia
wasmaintained for 10 days bymeans of subcutaneousmeloxi-
cam (Metacam, Boehringer Ingelheim, S.A) administration
(0.3mg/kg the day of surgery and 0.15mg/kg for 10 days after
surgery).
Sheep were euthanized at 3 weeks, 3months, or 6months,
depending on the study. Euthanasia was performed bymeans
of an overdose of sodium pentobarbital (Vetoquinol S.A)
(60mg/kg) given intravenously after a previous sedation. A
necropsy followed by an internal examination of the thoracic
and abdominal cavities was performed.The vaginawas exam-
ined in order to assess the degree of fibrosis, possible mesh
folding, infection, or vaginal erosion. Mesh implantation
sites, including the mesh, the vagina, and rectum (opened
longitudinally), were resected and fixed in a 4% formaldehyde
solution altogether for histopathological assessment.
2.5. Clinical Evaluation. Animals were clinically monitored
throughout the studies to assess possible discomfort and/or
pain. For the first week after the surgery, animals were
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Table 2: Clinical signs monitored during in vivo study.
Parameter Score
Claudication None = 0; mild = 1; moderate = 2; severe = 3
Posture None = 0; it stands up without forcing but with difficult = 1; it needs to be forced to stand up = 2; does notstand up even being forced = 3
Mucous coloration Pink = 0; pale = 1; cyanotic = 3
Corporal temperature Fever: none = 0; mild = 1; severe = 3
Wound appearance Inflammation: none = 0; mild = 1; moderate = 2; severe = 3
Food ingestion Decrease on ingestion: none = 0; mild = 1; moderate = 2; complete anorexia = 3
Feces/urine Normal = 0; abnormal = 3
Total score 21
checked every day. The following week they were checked on
alternate days, and on the third week they were monitored
twice per week. For animals included in the 3- and 6-month
follow-up study, they were monitored once a week from the
fourth week onwards. Parameters monitored are displayed in
Table 2.
Body weight gain was monitored in order to assess if the
postsurgical period and subsequentmesh integration affected
the body weight performance. Animals monitored for three
weeks were weighed before surgery and at the end of the
study. For animals included in the main study, weight control
was performed once monthly.
2.6. Macroscopy. A semiquantitative score was applied dur-
ing necropsy for all animals, including the assessment of the
following parameters: fibrosis, presence of abscesses, mesh
folding, vaginal exposure, intestinal exposure, and vaginal
stricture (considered as obliteration in the vaginal lumen due
to massive tissue ingrowth). Fibrosis was scored as 0 (none),
1 (slight), 2 (moderate), and 3 (intense). Abscess presence
was scored as 0 (none), 1 (one abscess <0.5 cm), 2 (several
abscesses <0.5 cm), and 3 (one or more abscesses >0.5 cm).
The presence or absence of vaginal erosion, mesh folding,
and vaginal stricture was assessed as percentage of prevalence
in each group. This macroscopic score is the result of the
assessment during necropsy and tissue trimming. During
tissue trimming, the whole vagina with the mesh and the
rectum were cut into several transversal slices and they were
visually assessed to complete the necropsy score (Figures
3(a), 3(b), and 3(c)). Parameters like mesh folding were easily
detected with these transversal cuts. Five slices were selected
and processed into paraffin blocks, which were afterwards
evaluated histologically.
2.7. Histopathology. 2𝜇m thick slides were cut for each of the
5 blocks processed from each animal. The slides were stained
with hematoxylin-eosin and evaluated by a pathologist. Dig-
ital images were obtained with a light microscope (Leica DM
6000B) coupled with a digital camera (Leica DFC480; Leica
Microsystems CMS GmBh, Germany). A semiquantitative
histological score for each of the slides was performed and
the mean score of the five preparations was calculated.
2.8. Statistical Analysis. All statistical analysis was performed
using GraphPad Prism 4 (GraphPad Software, La Jolla, CA,
USA). Data are expressed as mean ± SEM. Histological
scoring results from the main study group were compared
with the results of the PP-1-Hist posterior group of the first
pilot study by means of paired 𝑡-test with 95% of confidence
interval. Histological results from the two different periods
of follow-up in the main study were also compared amongst
them.
3. Results
3.1. Clinical Evaluation. Overall, the daily score of clinical
signs was low in all groups of animals, not exceeding 1.5
points out of 21 (Table 3). Clinical signsweremainly related to
wound appearance, which lasted generally until the wound
was totally healed. The episiotomy wound underwent a nor-
mal healing process in all animalswithout finding any specific
complications. The highest clinical symptoms were found in
the pilot studies, specifically in the animals which were
implanted anteriorlywith PPmesh anchoredwith PP stitches.
Apart from apathy and decrease of food ingestion in some of
the affected animals, the rest of the clinical signs monitored
throughout the studies were absent during the experimental
periods. Overall, the clinical score was higher in animals in
which mesh vaginal exposure was detected macroscopically
or microscopically. Apathy including unwillingness to stand
up was observed in the first pilot study, within the PP-1-
Hist posterior group, where one of the ewes suffered an anus-
vaginal fistula. In this case, additional analgesic treatmentwas
supplied by means of subcutaneous buprenorphine. There
were no significant differences in body weight gain amongst
the studied groups.
3.2. Macroscopy. The main macroscopic findings are shown
in Table 3 and Figure 2. Overall, the two groups belonging to
the main study with Synthetic PP Mesh-1 in combination
with device appliedHistoacryl displayed lessmesh exposures,
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Table 3: Data showing clinical and macroscopic scores in pilot study groups and main study groups (bold). Note that mean daily clinical
score is based on 21 days for pilot studies and on 3 and 6 months in the definitive study.
Experimental group Mean daily clinical
score (up to 21 points)
Macroscopic score
Fibrous
reaction Abscesses
Vaginal
exposure
Intestinal
exposure
Mesh
folding
Vaginal
stricture
PP-1-Hist anterior (5 × 5 cm) 0.42 2.33 1 2/3 0/3 2/3 0/3
PP-1-Hist posterior (5 × 5 cm) 0.60 2.67 1b 2/3 1/3 1/3 0/3
PP-1-PP anterior (3 × 4 cm) 1.00 2 0 1/1 0/1 1/1 0/1
PP-1-PP posterior (4 × 4 cm) 0.77 3 1b 1/1 0/1 1/1 0/1
Omy-TF-PP posterior (2-3 × 3-3 cm) 0.63 1.5 0 0/2 0/2 0/2 0/2
PP-2-PP anterior (2 × 2 cm) 0.85 2 0 0/1 0/1 0/1 0/1
PP-2-PP posterior (3 × 3 cm) 0.46 3 3 1/1 0/1 1/1 0/1
PP-1-Hist-3m (3–3.5 × 3.2–3.5) 0.42 1.75 0/4 0/4 0/4 0/4 0/4
PP-1-Hist-6m (3–3.5 × 3.2–3.5) 0.28 1 0/4 0/4 0/4 1/4a 0/4
aFold in one of the corners of the mesh. It does not represent the complete folding of the mesh.
bAbscesses detected by histology of approximately 5mm of diameter but considered as macroscopic finding.
(a) (b) (c) (d)
Figure 2: Photographs showing some of the macroscopic findings described during tissue trimming. (a) PP-1-Hist-6 month group. Note the
good position of the mesh despite the slight folding in one of the corners, which was the unique macroscopic finding observed in this group.
(b) PP-1-Hist posterior 3 wk group. Note the complete folding of the mesh with exposure of the mesh into the vaginal cavity (dashed arrow)
and into the colonic cavity (continuous arrow). (c) PP-2-PP posterior. Abscess associated to one of the polypropylene stitches. (d) PP-1-PP
anterior 3 wk. Extrusion of the mesh into the vagina.
mesh folding, and abscesses. There was only one animal in
which the mesh was partially folded in one corner, without
causing further complications (Figure 2(a)).
3.3. Histopathology. The best implant integration within the
tissue was observed in the main study (synthetic PP mesh-
1 and device applied Histoacryl) as well as in the pilot study
with cPTFE mesh (Table 4). The inflammatory reaction was
also very low in the main study, being almost nonexistent
in the explants examined at 6 months postimplantation. In
these 8 animals, there were no cases of vaginal ulceration or
even vaginal epithelial inflammation. The mesh was evenly
distributed and situated between the rectal musculature and
the dorsal vaginal wall, displaying a solid bridging fibrosis
(Figure 3(b)) which had also significantly higher scores of
mesh integration with respect to the first pilot study (𝑃 <
0.05).
4. Discussion
The aim of this study was to find a proper experimental
approach and assess the performance of a low-weight PP
mesh with large pore (≥2mm) anchored with surgical glue
(Histoacryl) in pelvic floor surgery in a sheep model. After
6 BioMed Research International
(a)
RM
Hist.
VL
(b)
RM
(c)
∗
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Figure 3: Histological hematoxylin-eosin stained sections of the different implants. (a) PP-1-Hist-6m group showing good integration of the
PPmesh with slight foreign body reaction. (b) PP-1-Hist-3m group showing good integration of themesh andHistoacryl (Hist.) with flattened
position and good location versus vaginal lumen (VL) and rectal musculature (RM). (c)Omy-TF-PP posterior group showing proper location
of the mesh and good integration. (d) PP-1-Hist anterior group showing a purulent reaction (asterisk) and folding of the mesh. (e) PP-1-PP
anterior group showing folding of the mesh and vaginal inflammation and erosion with vaginal epithelium (VE) ulceration. (f) PP-2-PP
posterior group showing vaginal inflammation and ulceration due to mesh exposure.
3 and 6 months of follow-up, the tissue integration was good
together with an inexistent rate of graft-related complications
(GRCs). The comparison of this suitable combination with
other synthetic mesh materials and fixation methods within
the study shows that a proper mesh size and a good fixation
method to avoid folding and mesh exposures are key features
for a good performance of pelvic floor implanted synthetic
meshes.
The sheep has been explored in recent years as a pre-
clinical animal model in pelvic floor disorders [10, 11]. Its
good behavior, inexpensiveness, and similarities with women
in terms of predisposition to suffer from POP make sheep
a suitable model. Despite being a quadruped animal, it can
help predict the behavior of biologic/synthetic graftmaterials
used in pelvic floor reconstruction, providing information
related to postoperative pain, as seen in the present study.
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Indeed, this is the first preclinical study correlating mesh
histocompatibility with clinical symptoms in sheep.
One of the most serious complications resulting from
pelvic floor synthetic mesh implantation in women is the
occurrence of dyspareunia, which is normally related to
mesh exposure into the vagina [6, 7]. The assessment of
clinical parameters such as food intake, animal posture, or
wound appearance has allowed us to obtain a clinical score
which correlates to a large extent with the outcome of the
implanted grafts.The highest clinical scores were obtained for
the meshes implanted between the urinary bladder and the
vagina (anterior site), which has been also proven to be a loca-
tion more liable to complications in women [12]. Perfecting
this clinical assessment together with the development of a
semiquantitative system for assessing local pain would help
obtain very valuable data in these preclinical studies.
Vaginal mesh exposure or even extrusion of the mesh
into the vagina is the main complication in pelvic floor
reconstruction with synthetic meshes. Thus, nowadays, an
effort for standardization of symptoms and severity related
to POP complications is being made in order to address the
best treatment approach for each patient [13]. As previously
reported [14],mesh exposures were detected in our study.The
highest mesh exposure rate was of 66% of animals in the first
pilot study. As suggested by [15], a big mesh size could trigger
the presence of graft-related complications (GRCs). This fact
might be one of the reasons of the high prevalence of vaginal
mesh extrusion. In fact, the reduction of mesh size in the
long-term study leads to better results. In our case, the use
of an excessive amount of surgical glue (Histoacryl) might be
also helping in the high prevalence of vaginalmesh extrusion.
At the same time, mesh exposure/extrusion clearly correlated
with the presence of mesh folding, a fact that has also been
observed clinically [7].
Good mesh fixation is crucial to avoid complications.
Mesh stiffness has been pointed out as a factor directly related
to the avoidance of mesh folding [15, 16]. The combination
of the condensed polytetrafluoroethylene Omyra mesh with
PP suture was the only combination tested in our pilot
studies which obtained integration and inflammatory results
as good as those obtainedwith the PPMesh-1withHistoacryl.
The high stiffness offered by the Omyra cPTFE mesh could
be the reason for this good performance, allowing a flat
position with avoidance of folds and leading to a good i
ntegration.
Polypropylene is known as an inert synthetic material
with good integration, being the most used synthetic graft
material. Nowadays, the low-weight PP meshes with large
pore size are the first choice because they allow a better tissue
ingrowth with better graft integration [17, 18]. However, these
meshes are very soft and prone to folds. When combining
the PP Mesh-1 with Histoacryl as a fixation method, the
glue polymerization provides the PP mesh with a degree of
stiffness that helps achieve a good position and avoidance of
folds. This n-butyl-2-cyanoacrylate synthetic glue has been
extensively used for wound closure and has recently been
proven to be a good alternative method for mesh fixation in
hernias [19–21]. In our study, for the first time, we assessed
in vivo the outcome of n-butyl-2-cyanocrylate as fixation
method for synthetic mesh placement in pelvic floor surgery
using the sheep as a model. In our experience, when the glue
was applied manually by means of a syringe, it was difficult to
control the amount of glue placed and, in consequence, large
volumes of surgical glue led to a pyogranulomatous foreign
body inflammation which was hard to reabsorb and caused
mesh folding, exposure, and/or infection as seen in the first
pilot study.Moreover, large amounts of gluemay be impairing
tissue ingrowth through the mesh pores, leading to poor
tissue integration. In contrast, the use of Histoacryl Pro-Set
OFX applicator allowed us to control the appropriate volume
of adhesive which conferred the proper level of strength for
fixation allowing a good integration of the surrounding tissue.
No complications or side effects were observed in the animals
after 3 and 6 months of follow-up, with the mesh being well
fixed and integrated in all cases.
In summary, our study demonstrates that the use of light
weight Polypropylene-1 mesh in combination with n-butyl-2-
cyanocrylate glue (Histoacryl) applied withHistoacryl Pro-Set
OFX applicator in sheep does not induce any graft-related
complications in pelvic floor implantation and provides a
good histological integration.
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